Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.34 USD | +5.33% | +2.47% | -26.06% |
Apr. 15 | Goldman Sachs Cuts Veracyte Price Target to $28 From $32, Maintains Buy Rating | MT |
Feb. 26 | Morgan Stanley Trims Veracyte's Price Target to $21 From $22, Keeps Underweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.06% | 1.55B | |
-20.55% | 10.81B | |
+47.97% | 3.36B | |
-32.75% | 2.22B | |
-14.15% | 2.16B | |
+19.85% | 1.04B | |
-2.62% | 746M | |
-31.67% | 425M | |
-43.88% | 405M | |
+29.03% | 378M |
- Stock Market
- Equities
- VCYT Stock
- News Veracyte, Inc.
- Needham Adjusts Price Target on Veracyte to $33 From $31, Maintains Buy Rating